What are the indications for Spontaneous Bacterial Peritonitis (SBP) prophylaxis in patients with cirrhosis and ascites?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Indications for Spontaneous Bacterial Peritonitis (SBP) Prophylaxis

All patients with cirrhosis and ascites who have recovered from one episode of SBP should receive continuous antibiotic prophylaxis with norfloxacin 400 mg daily (or ciprofloxacin 500 mg once daily), as this reduces recurrence from 68% to 20% and improves survival. 1, 2

Secondary Prophylaxis (Highest Priority)

Patients with prior SBP require lifelong prophylaxis unless they undergo liver transplantation, as the one-year recurrence rate without prophylaxis approaches 70% and one-year mortality is 50-70%. 2, 3

  • Norfloxacin 400 mg once daily is the first-line agent, reducing SBP recurrence from 68% to 20% and improving three-month survival from 62% to 94%. 1, 2
  • Ciprofloxacin 500 mg once daily is an acceptable alternative, commonly used in the UK. 1, 3
  • All patients with prior SBP should be evaluated for liver transplantation due to poor long-term prognosis. 1, 3

Primary Prophylaxis

Patients with low ascitic fluid protein (<15 g/L) combined with advanced liver disease should receive prophylaxis, as this population has high risk for first SBP episode. 2, 3

Specific high-risk criteria warranting primary prophylaxis include:

  • Ascitic fluid protein <15 g/L (some guidelines use <10 g/L cutoff) with any of the following: 2, 3

    • Child-Pugh score ≥9 2
    • Serum bilirubin ≥3 mg/dL (or ≥2.5 mg/dL per some criteria) 3, 4
    • Impaired renal function 2
    • Hyponatremia 2
  • Norfloxacin 400 mg daily reduces one-year probability of developing SBP from 61% to 7% in this population. 2

Gastrointestinal Bleeding

All cirrhotic patients with gastrointestinal bleeding require antibiotic prophylaxis regardless of ascites status, as this is the most frequently overlooked indication in clinical practice. 3, 4

  • For severe liver disease, IV ceftriaxone 1g daily for 7 days is recommended. 3
  • GI hemorrhage accounted for 44% of preventable SBP cases in one analysis. 4

Antibiotic Selection and Alternatives

  • Norfloxacin 400 mg daily remains the most extensively studied and recommended first-line agent. 1, 3
  • Ciprofloxacin 500 mg once daily is an acceptable alternative with similar efficacy. 1, 2
  • Trimethoprim-sulfamethoxazole (800/160 mg once daily) can be used but has higher adverse event rates than norfloxacin. 2, 5
  • Rifaximin may be more effective than norfloxacin for secondary prophylaxis with fewer adverse events, though less extensively studied. 5

Critical Pitfalls and Considerations

Long-term quinolone prophylaxis increases risk of gram-positive infections (79% vs 67%), including MRSA, which should prompt consideration of alternative antibiotics in patients with breakthrough infections. 1, 3

  • Monitor for quinolone side effects including tendon inflammation, particularly in patients with renal impairment. 2, 3
  • Consider local bacterial resistance patterns when selecting prophylactic antibiotics. 2, 3
  • Avoid weekly ciprofloxacin regimens as they may promote quinolone-resistant organisms. 2
  • Restrict proton pump inhibitor use in cirrhotic patients, as PPIs increase SBP risk. 2, 3
  • Perform diagnostic paracentesis if clinical deterioration occurs despite prophylaxis. 2

Adherence Gap

62% of SBP cases in one study were potentially preventable through proper adherence to prophylaxis guidelines, with GI hemorrhage being the most commonly missed indication. 4 Only one-third of patients who survived SBP received appropriate long-term outpatient prophylaxis after discharge. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Norfloxacin Dosage for SBP Prophylaxis in Cirrhotic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

SBP Prophylaxis in Cirrhosis: Indications and Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Potential preventability of spontaneous bacterial peritonitis.

Digestive diseases and sciences, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.